153 related articles for article (PubMed ID: 34830153)
1. New Bioactive Fused Triazolothiadiazoles as Bcl-2-Targeted Anticancer Agents.
Hamdy R; Jones AT; El-Sadek M; Hamoda AM; Shakartalla SB; Al Shareef ZM; Soliman SSM; Westwell AD
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830153
[TBL] [Abstract][Full Text] [Related]
2. Design, Synthesis and Evaluation of New Bioactive Oxadiazole Derivatives as Anticancer Agents Targeting Bcl-2.
Hamdy R; Elseginy SA; Ziedan NI; El-Sadek M; Lashin E; Jones AT; Westwell AD
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33256166
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of 3-(benzylthio)-5-(1H-indol-3-yl)-1,2,4-triazol-4-amines as Bcl-2 inhibitory anticancer agents.
Hamdy R; Ziedan N; Ali S; El-Sadek M; Lashin E; Brancale A; Jones AT; Westwell AD
Bioorg Med Chem Lett; 2013 Apr; 23(8):2391-4. PubMed ID: 23474389
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of 5-(1H-indol-3-yl)-N-aryl-1,3,4-oxadiazol-2-amines as Bcl-2 inhibitory anticancer agents.
Hamdy R; Ziedan NI; Ali S; Bordoni C; El-Sadek M; Lashin E; Brancale A; Jones AT; Westwell AD
Bioorg Med Chem Lett; 2017 Feb; 27(4):1037-1040. PubMed ID: 28087272
[TBL] [Abstract][Full Text] [Related]
5. Indole-coumarin-thiadiazole hybrids: An appraisal of their MCF-7 cell growth inhibition, apoptotic, antimetastatic and computational Bcl-2 binding potential.
Kamath PR; Sunil D; Joseph MM; Abdul Salam AA; T T S
Eur J Med Chem; 2017 Aug; 136():442-451. PubMed ID: 28525842
[TBL] [Abstract][Full Text] [Related]
6. Efficient T3P
Kamath PR; Sunil D; Das S; Abdul Salam AA; Rao BS
Chem Biol Interact; 2017 Apr; 268():53-67. PubMed ID: 28235427
[TBL] [Abstract][Full Text] [Related]
7. New Quinoline-Based Heterocycles as Anticancer Agents Targeting Bcl-2.
Hamdy R; Elseginy SA; Ziedan NI; Jones AT; Westwell AD
Molecules; 2019 Apr; 24(7):. PubMed ID: 30986908
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of 3,6-disubstituted [1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives as a novel class of potential anti-tumor agents.
Ibrahim DA
Eur J Med Chem; 2009 Jul; 44(7):2776-81. PubMed ID: 19203813
[TBL] [Abstract][Full Text] [Related]
9. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
[TBL] [Abstract][Full Text] [Related]
10. Benzimidazole clubbed with triazolo-thiadiazoles and triazolo-thiadiazines: new anticancer agents.
Husain A; Rashid M; Shaharyar M; Siddiqui AA; Mishra R
Eur J Med Chem; 2013 Apr; 62():785-98. PubMed ID: 23333063
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and cytotoxicity evaluation of some novel thiazoles, thiadiazoles, and pyrido[2,3-d][1,2,4]triazolo[4,3-a]pyrimidin-5(1H)-ones incorporating triazole moiety.
Gomha SM; Ahmed SA; Abdelhamid AO
Molecules; 2015 Jan; 20(1):1357-76. PubMed ID: 25594346
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of novel 1,2,4-triazoles, triazolothiadiazines and triazolothiadiazoles as potential anticancer agents.
Kamel MM; Megally Abdo NY
Eur J Med Chem; 2014 Oct; 86():75-80. PubMed ID: 25147148
[TBL] [Abstract][Full Text] [Related]
13. Identification of Novel Class of Triazolo-Thiadiazoles as Potent Inhibitors of Human Heparanase and their Anticancer Activity.
Baburajeev CP; Mohan CD; Rangappa S; Mason DJ; Fuchs JE; Bender A; Barash U; Vlodavsky I; Basappa ; Rangappa KS
BMC Cancer; 2017 Mar; 17(1):235. PubMed ID: 28359266
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and anticancer activity of 5-(3-indolyl)-1,3,4-thiadiazoles.
Kumar D; Maruthi Kumar N; Chang KH; Shah K
Eur J Med Chem; 2010 Oct; 45(10):4664-8. PubMed ID: 20692741
[TBL] [Abstract][Full Text] [Related]
15. Benzimidazole bearing oxadiazole and triazolo-thiadiazoles nucleus: design and synthesis as anticancer agents.
Husain A; Rashid M; Mishra R; Parveen S; Shin DS; Kumar D
Bioorg Med Chem Lett; 2012 Sep; 22(17):5438-44. PubMed ID: 22840417
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, crystal structure and biological evaluation of some novel 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles and 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazines.
Khan I; Zaib S; Ibrar A; Rama NH; Simpson J; Iqbal J
Eur J Med Chem; 2014 May; 78():167-77. PubMed ID: 24681981
[TBL] [Abstract][Full Text] [Related]
17. Discovery of [1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives as novel, potent and selective c-Met kinase inhibitors: Synthesis, SAR study, and biological activity.
Zhang L; Zhao J; Zhang B; Lu T; Chen Y
Eur J Med Chem; 2018 Apr; 150():809-816. PubMed ID: 29602036
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and Cytotoxic Activity of New 1,3,4-Thiadiazole Thioglycosides and 1,2,3-Triazolyl-1,3,4-Thiadiazole
Alminderej FM; Elganzory HH; El-Bayaa MN; Awad HM; El-Sayed WA
Molecules; 2019 Oct; 24(20):. PubMed ID: 31623291
[TBL] [Abstract][Full Text] [Related]
19. 1-Phenyl-1H-indole derivatives as a new class of Bcl-2/Mcl-1 dual inhibitors: Design, synthesis, and preliminary biological evaluation.
Xu G; Liu T; Zhou Y; Yang X; Fang H
Bioorg Med Chem; 2017 Oct; 25(20):5548-5556. PubMed ID: 28866374
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, antimicrobial and anti-cancer activities of some new N-ethyl, N-benzyl and N-benzoyl-3-indolyl heterocycles.
El-Sawy ER; Mandour AH; Mahmoud K; Islam IE; Abo-Salem HM
Acta Pharm; 2012 Jun; 62(2):157-79. PubMed ID: 22750815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
